Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens

Published:2019-12-04 Issue:2 Volume:80 Page:214-224
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Ylitalo Erik Bovinder¹,Thysell Elin¹,Thellenberg‐Karlsson Camilla²,Lundholm Marie¹,Widmark Anders²,Bergh Anders¹,Josefsson Andreas³⁴⁵^ORCID,Brattsand Maria¹^ORCID,Wikström Pernilla¹^ORCID

Affiliation:

1. Department of Medical Biosciences, PathologyUmeå University Umeå Sweden

2. Department of Radiation Sciences, OncologyUmeå University Umeå Sweden

3. Department of Urology, Sahlgrenska Cancer Center, Institute of Clinical Sciences, Sahlgrenska AcademyUniversity of Gothenburg Gothenburg Sweden

4. Department of Surgical and Perioperative Sciences, Urology and AndrologyUmeå University Umeå Sweden

5. Wallenberg Centre for Molecular MedicineUmeå University Umeå Sweden

Funder

Cancerfonden

Vetenskapsrådet

Umeå Universitet

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23935

Reference34 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Molecular States Underlying Androgen Receptor Activation: A Framework for Therapeutics Targeting Androgen Signaling in Prostate Cancer

3. Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy

4. Abiraterone and Increased Survival in Metastatic Prostate Cancer

5. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer;Molecular Cancer Research;2024-04-22

2. Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14);Acta Oncologica;2023-04-03

3. Three-in-one: exploration of co-encapsulation of cabazitaxel, bicalutamide and chlorin e6 in new mixed cyclodextrin-crosslinked polymers;RSC Advances;2023

4. Transcriptomic Profiling Analysis of Castration-Resistant Prostate Cancer Cell Lines Treated with Chronic Intermittent Hypoxia;Cancers;2022-08-16

5. Clinicopathological characteristics of androgen receptor splicing variant 7 (AR-V7) expression in patients with castration resistant prostate cancer: A systematic review and meta‐analysis;Translational Oncology;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3